Clinical Trial Update: Mitigating Delirium With Fluvoxamine Treatment for Non-Cardiac Surgery [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating fluvoxamine to mitigate delirium after non-cardiac surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium
• Postoperative Complications

Drugs mentioned

• Luvox (Fluvoxamine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Delirium, Surgery-Complications | Phase 3 | Status: RECRUITING